TESARO INC's ticker is TSRO and the CUSIP is 881569107. A total of 93 filers reported holding TESARO INC in Q4 2013. The put-call ratio across all filers is 2.85 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $3,480,000 | +21.6% | 89,202 | +38.6% | 0.03% | +12.5% |
| Q2 2018 | $2,862,000 | -0.1% | 64,354 | +28.3% | 0.02% | -17.2% |
| Q1 2018 | $2,865,000 | -55.5% | 50,140 | -35.5% | 0.03% | -35.6% |
| Q4 2017 | $6,439,000 | -19.6% | 77,701 | +35.8% | 0.04% | -45.8% |
| Q2 2017 | $8,005,000 | +50.5% | 57,233 | +65.5% | 0.08% | +33.9% |
| Q1 2017 | $5,320,000 | +478.9% | 34,576 | +405.9% | 0.06% | +588.9% |
| Q4 2016 | $919,000 | +25.2% | 6,834 | -6.6% | 0.01% | +12.5% |
| Q3 2016 | $734,000 | +189.0% | 7,320 | +15.7% | 0.01% | +100.0% |
| Q3 2015 | $254,000 | +1.2% | 6,329 | +48.5% | 0.00% | 0.0% |
| Q2 2015 | $251,000 | -69.2% | 4,261 | -70.0% | 0.00% | -69.2% |
| Q1 2015 | $815,000 | +68.0% | 14,193 | +8.7% | 0.01% | +85.7% |
| Q4 2014 | $485,000 | -24.5% | 13,053 | -45.2% | 0.01% | -30.0% |
| Q3 2014 | $642,000 | +13.6% | 23,832 | +31.2% | 0.01% | +11.1% |
| Q2 2014 | $565,000 | +11.2% | 18,162 | +1.1% | 0.01% | +12.5% |
| Q4 2013 | $508,000 | – | 17,973 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 2,021,403 | $271,838,000 | 64.82% |
| NEA Management Company, LLC | 10,275,113 | $1,381,797,000 | 54.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,248,086 | $167,843,000 | 27.84% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 89,695 | $12,062,000 | 7.28% |
| Perceptive Advisors | 687,993 | $92,521,000 | 6.58% |
| Avoro Capital Advisors LLC | 231,700 | $31,159,000 | 6.30% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,500 | $12,705,000 | 5.72% |
| Rock Springs Capital Management LP | 613,500 | $82,503,000 | 5.52% |
| SENZAR ASSET MANAGEMENT, LLC | 142,300 | $19,136,000 | 5.08% |
| BB BIOTECH AG | 974,582 | $131,062,000 | 4.85% |